|
Volumn 2, Issue 5, 2001, Pages 813-818
|
Bacterial resistance in urinary tract infections: How to stem the tide
|
Author keywords
Antibiotics; Resistance; Urinary tract infection
|
Indexed keywords
AMIKACIN;
AMOXICILLIN PLUS CLAVULANIC ACID;
AMPICILLIN;
ANTIBIOTIC AGENT;
CEFALOTIN;
CEFAZOLIN;
CEFEPIME;
CEFTAZIDIME;
CEPHALOSPORIN DERIVATIVE;
CIPROFLOXACIN;
COTRIMOXAZOLE;
GENTAMICIN;
IMIPENEM;
MECILLINAM;
NEW DRUG;
NITROFURANTOIN;
PIPERACILLIN PLUS TAZOBACTAM;
PIVMECILLINAM;
QUINOLINE DERIVED ANTIINFECTIVE AGENT;
QUINOLONE DERIVATIVE;
SULFAFURAZOLE;
TEICOPLANIN;
TETRACYCLINE;
TRIMETHOPRIM;
VANCOMYCIN;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC SENSITIVITY;
BACTERIAL MUTATION;
COMMUNICABLE DISEASE;
COMMUNITY CARE;
CONTROLLED STUDY;
DIAGNOSTIC PROCEDURE;
DRUG EFFICACY;
DRUG SAFETY;
DRUG USE;
EMPIRICISM;
ESCHERICHIA COLI;
HOSPITAL INFECTION;
HUMAN;
INFECTION RISK;
MEDICAL INFORMATION;
NONHUMAN;
PREVALENCE;
REVIEW;
RISK ASSESSMENT;
URINARY TRACT DISEASE;
URINARY TRACT INFECTION;
ANTI-BACTERIAL AGENTS;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
URINARY TRACT INFECTIONS;
|
EID: 0034878863
PISSN: 14656566
EISSN: None
Source Type: Journal
DOI: 10.1517/14656566.2.5.813 Document Type: Review |
Times cited : (9)
|
References (29)
|